Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 12 March 2025 - 15:50

Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, Date of authorisation: 25/03/2022, Revision: 9, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/evusheld

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters